STOCK TITAN

HNGE (NYSE) insider sale: James Pursley sells 15,000 shares under 10b5-1

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

James Pursley reported a sale of 15,000 common shares. The filing shows 15,000 shares sold under a 10b5-1 plan on 02/23/2026 for $589,983. The securities originated as Performance Stock Units granted 04/01/2023 and the broker listed is Morgan Stanley Smith Barney LLC. The notice was filed on 03/23/2026.

Positive

  • None.

Negative

  • None.

Insights

10b5-1 sale of 15,000 shares by James Pursley reported; proceeds shown as $589,983.

The report states a 10b5-1 sale executed on 02/23/2026 for $589,983, affecting 15,000 common shares that trace to Performance Stock Units dated 04/01/2023. The broker listed is Morgan Stanley Smith Barney LLC.

Timing and pricing are supplied in the excerpt; cash‑flow recipient is the selling holder per the 10b5-1 sale. Subsequent filings may disclose any remaining holding amounts or additional plan details.

Sale executed under a pre-arranged trading plan, indicating an orderly disposition rather than a discretionary open-market decision.

The filing explicitly labels the transaction as a 10b5-1 sale, which is typically a pre-established plan for insiders to sell shares. The listed grant origin is Performance Stock Units dated 04/01/2023.

Documented broker involvement and the filing date 03/23/2026 complete the disclosure; the excerpt does not state post-transaction holdings or additional plan terms.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did James Pursley report in the Form 144 for HNGE?

He reported selling 15,000 common shares under a 10b5-1 plan on 02/23/2026. The filing shows proceeds of $589,983 and lists Morgan Stanley Smith Barney LLC as the broker.

Were the sold shares part of an award or grant for HNGE?

Yes — the filing ties the securities to Performance Stock Units granted on 04/01/2023. The excerpt lists the grant date and 15,000 shares as the instrument origin.

What proceeds were reported for the 15,000-share sale?

The excerpt reports aggregate proceeds of $589,983 for the sale executed on 02/23/2026. A separate figure of $637,200 appears in the form fields but the sale line shows $589,983.

Investors should rely on the specific sale row as the transaction amount.

Which broker handled the reported transaction?

The filing lists Morgan Stanley Smith Barney LLC (New York Plaza) as the broker for the transaction. The broker and address are provided on the form's securities-to-be-sold section.

When was the Form 144 notice filed for this sale?

The notice in the excerpt is dated 03/23/2026. The underlying 10b5-1 sale occurred on 02/23/2026, as shown in the sold-during-the-past-3-months row.
Hinge Health, Inc.

NYSE:HNGE

View HNGE Stock Overview

HNGE Rankings

HNGE Latest News

HNGE Latest SEC Filings

HNGE Stock Data

3.35B
48.29M
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SAN FRANCISCO